Brief: Moberg Pharma Q4 EBITDA Loss Widens To SEK 8.0 Million
Feb 13 (Reuters) - Moberg Pharma AB (publ) MBPH.ST :
* Q4 EBITDA SEK -8.0 MILLION (-4.0)
* Q4 PROFIT AFTER TAX SEK -6.4 MILLION (-3.1)
* Q4 DILUTED EARNINGS PER SHARE SEK -0.23 (-0.32)
Source text for Eikon: ID:nWkrbmBLF3
Further company coverage: MBPH.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Moberg Pharma AB (publ)
See all newsSweden's Moberg Pharma Q2 loss narrows as revenue rises
Brief: Moberg Pharma Q2 EBITDA SEK -4.3 Million
Brief: Moberg Pharma Names Vaidrius Navikas Chief Medical Officer
Brief: Moberg Pharma And Karo Healthcare Expand Collaboration
Moberg Pharma Q1 revenue rises, losses narrow on Nordic market share gains